RxDoctor Payments Data

Alla Bodner, MD

Obstetrics & Gynecology · Grayslake, ILNPI 1669723573

Payments from drug & device makers

$3,850in general payments, 2019–2025

Across 193 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$499
  • Novo Nordisk$349
  • Exeltis, USA Inc.$322
  • Mayne Pharma Commercial LLC$298
  • Hologic Sales And Service, LLC$214
  • Coopersurgical, Inc.$213
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$3,850100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,850 in reported general payments places this provider in the 85th percentile of 1,732 obstetrics & gynecology providers in Illinois.

See all obstetrics & gynecology providers in Illinois

Medicare billing

Part B allowed, 2024
$60,768
Medicare patients
89
Services billed
773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase24$20,910
OzempicSemaglutide11$20,466
EliquisApixaban26$18,930
Breo ElliptaFluticasone/Vilanterol11$3,891
Dexlansoprazole DrDexlansoprazole14$2,823
Pentoxifylline59$1,424
Rosuvastatin Calcium37$645
Alprazolam28$561
Hydralazine Hcl30$521
Fluticasone Propionate23$414
Omeprazole32$406
Atorvastatin Calcium75$370
Gabapentin29$305
Ibuprofen13$298
Diclofenac Sodium11$273

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon$499$20,91024 claims
Novo NordiskOzempic$349$20,46611 claims
PfizerEliquis$159$18,93026 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,732 obstetrics & gynecology providers in Illinois.

Other obstetrics & gynecology in Grayslake

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →